Rene Kantehm

HarvestAi is a cutting-edge technology company that specializes in developing sophisticated forecasting models for indoor farms. With support from leading accelerator programs at MIT and Oxford, our team of experts uses advanced machine learning and computer vision technologies to predict harvest dates and yields with unparalleled accuracy. We are proud to be backed by the European Union and Brandenburg Kapital, and have received nearly EUR 2.7M in pre-seed funding, which is a testament to the strength and potential of our innovative solutions. At HarvestAi, we are committed to helping indoor farmers achieve greater efficiency, sustainability, and profitability, while ensuring that consumers have access to fresh, high-quality produce year-round. Join us on this exciting journey towards a more sustainable future! We are always keen on exchanging ideas. Are you an investor, a grower, or looking for a job? Lets talk!

Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system. Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood in multiple immune-related disorders.

@Alacris Theranostics GmbH – Innovation leader in precision oncology! “We want every cancer patient to have a bright future” 🔬 Join the Forefront of Cancer Molecular Diagnostics Our mission is to empower every cancer patient with the benefits of precision medicine. With a passionate team translating research into patient-centered diagnostic solutions, we offer best-in-class accredited Dx services that combine state-of-the-art Next Generation Sequencing (NGS) with our proprietary bioinformatics pipeline. 🧬 Unleash the Power of Comprehensive Tumor Profiling Experience a unique personalized Dx with our flagship solution, the Alacris-CMTA-TM (Comprehensive Molecular Tumor Analysis). By seamlessly integrating genomics and bulk transcriptomics, our ISO 15189 accredited CMTA Dx test provides unparalleled insights into somatic alterations and the tumor microenvironment. Unlocking potential drug targets, the CMTA actionable report empowers the oncologist to offer the best possible care, ultimately leading to improved outcomes. 🧬 Experience Our Outstanding NGS Services We harness the remarkable power of DNBSEQ-TM technology, developed by MGI, to provide NGS services of the highest quality. We operate medium (G400) to ultra-high throughput (T7) sequencers to accommodate a wide range of applications: whole genome / exome / RNA sequencing (WGS, WES, RNA-seq) and more. Trusted by clinical laboratories, academic institutions, and pharma alike, we also proudly serve the MMHP Million Microbiome Human Project. 🌍 Shaping the Future of Precision Medicine Discover ModCell-TM, our award-winning proprietary in silico mechanistic modeling technology that enables the simulation of patient-specific drug responses. Setting new benchmarks in pre-clinical cancer research, ModCell-TM paves the way for transformative advances in precision oncology. 🔗 To learn more about us, visit www.alacris-theranostics.com and join us in our journey to precision medicine excellence

Wir sind Europas größte digitale Hautarztpraxis – von Ärzt*innen gegründet, mehrfach ausgezeichnet, TÜV-zertifiziert und somit 100% datensicher. Patient*innen erhalten innerhalb von 24h eine ärztliche Diagnose und Therapieempfehlung für Hauterkrankungen über unserer gleichnamigen App “dermanostic”. Durch unseren Fokus auf die Dermatologie in Kombination mit technologischer Innovation erreichen wir die bestmögliche medizinische Qualität. Mit unserer App-Innovation schaffen wir eine vollständig digitalisierte Behandlung, die zeit- und ortsunabhängig selbst durchgeführt werden kann: Patient*innen erstellen drei Fotos von Ihrer Hautveränderung und füllen einen kurzen Fragebogen aus. Die Daten werden von einem Expert*innenteam (Fachärzt*innen und Professor*innen für Dermatologie) begutachtet und ausgewertet, ab 25€ pro Fall. Unsere Vision ist es, Patient*innen – egal wo auf der Welt – einen schnellen und unkomplizierten Zugang zu Hautärzt*innen zu ermöglichen. Wir freuen uns sehr, dass wir seit dem Markteintritt 2020 bereits 200.000 Patient*innen behandeln konnten!

HarvestAi is a cutting-edge technology company that specializes in developing sophisticated forecasting models for indoor farms. With support from leading accelerator programs at MIT and Oxford, our team of experts uses advanced machine learning and computer vision technologies to predict harvest dates and yields with unparalleled accuracy. We are proud to be backed by the European Union and Brandenburg Kapital, and have received nearly EUR 2.7M in pre-seed funding, which is a testament to the strength and potential of our innovative solutions. At HarvestAi, we are committed to helping indoor farmers achieve greater efficiency, sustainability, and profitability, while ensuring that consumers have access to fresh, high-quality produce year-round. Join us on this exciting journey towards a more sustainable future! We are always keen on exchanging ideas. Are you an investor, a grower, or looking for a job? Lets talk!

The X1F Group offers technology and transformation consulting from a single source, supporting banks, insurance companies, industry and the public sector in the digital transformation with a full service offering. Under its umbrella, X1F bundles specialized, innovative and complementary services for business process and management consulting, platform integration, data science, artificial intelligence, security, cloud architecture and IT infrastructure. X1F as a holding company, in which funds of the Swiss private investor group Ufenau Capital Partners hold the majority stake, generates annual revenues of more than 185 million euros with its twelve corporate subsidiaries and more than 1100 employees. It offers IT solutions at 38 locations in Europe, the USA, Canada and Australia. Legal Notice: https://x1f.one/en/legal-notice/ Privacy Policy: https://x1f.one/en/privacy-policy/

Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system. Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood in multiple immune-related disorders.

@Alacris Theranostics GmbH – Innovation leader in precision oncology! “We want every cancer patient to have a bright future” 🔬 Join the Forefront of Cancer Molecular Diagnostics Our mission is to empower every cancer patient with the benefits of precision medicine. With a passionate team translating research into patient-centered diagnostic solutions, we offer best-in-class accredited Dx services that combine state-of-the-art Next Generation Sequencing (NGS) with our proprietary bioinformatics pipeline. 🧬 Unleash the Power of Comprehensive Tumor Profiling Experience a unique personalized Dx with our flagship solution, the Alacris-CMTA-TM (Comprehensive Molecular Tumor Analysis). By seamlessly integrating genomics and bulk transcriptomics, our ISO 15189 accredited CMTA Dx test provides unparalleled insights into somatic alterations and the tumor microenvironment. Unlocking potential drug targets, the CMTA actionable report empowers the oncologist to offer the best possible care, ultimately leading to improved outcomes. 🧬 Experience Our Outstanding NGS Services We harness the remarkable power of DNBSEQ-TM technology, developed by MGI, to provide NGS services of the highest quality. We operate medium (G400) to ultra-high throughput (T7) sequencers to accommodate a wide range of applications: whole genome / exome / RNA sequencing (WGS, WES, RNA-seq) and more. Trusted by clinical laboratories, academic institutions, and pharma alike, we also proudly serve the MMHP Million Microbiome Human Project. 🌍 Shaping the Future of Precision Medicine Discover ModCell-TM, our award-winning proprietary in silico mechanistic modeling technology that enables the simulation of patient-specific drug responses. Setting new benchmarks in pre-clinical cancer research, ModCell-TM paves the way for transformative advances in precision oncology. 🔗 To learn more about us, visit www.alacris-theranostics.com and join us in our journey to precision medicine excellence